Thirumalai Chemicals Reports Q3 FY2024-25 Results: ₹498.26 Crore Revenue, ₹(-11.72) Crore Net Loss, Approves ₹700 Crore Fundraising

1738059566260.webp

Mumbai, India – January 28, 2025: Thirumalai Chemicals Limited (NSE: TIRUMALCHM, BSE: 500412) has announced its unaudited standalone and consolidated financial results for Q3 FY2024-25, posting a revenue of ₹498.26 crore and a net loss of ₹11.72 crore. The Board also approved a ₹700 crore fundraising to support capex and growth initiatives.

Key Financial Highlights – Q3 FY2024-25 (Standalone)

  • Revenue from Operations: ₹498.26 crore (YoY increase of 5.6% from ₹471.70 crore)
  • Total Income: ₹503.54 crore
  • Profit Before Tax (PBT): ₹(-11.72) crore (YoY decline from ₹(-1.14) crore)
  • Net Profit (PAT): ₹(-18.45) crore (YoY decline from ₹0.38 crore)
  • Earnings Per Share (EPS): ₹(-0.83).

Nine-Month Performance (April – December 2024) (Standalone)

  • Total Revenue: ₹1,578.60 crore (YoY increase of 5.5% from ₹1,491.21 crore)
  • Profit Before Tax (PBT): ₹59.49 crore
  • Net Profit (PAT): ₹44.70 crore
  • Earnings Per Share (EPS): ₹4.37 per share.

Key Financial Highlights – Q3 FY2024-25 (Consolidated)

  • Total Revenue: ₹446.65 crore (YoY decline of 9.2% from ₹491.90 crore)
  • Profit Before Tax (PBT): ₹(-49.91) crore
  • Net Profit (PAT): ₹(-42.02) crore
  • Earnings Per Share (EPS): ₹(-4.10) per share.

Strategic Developments & Key Announcements

  1. ₹700 Crore Fundraising Plan Approved:
    • Issuance of equity shares, debentures, non-convertible securities, or other instruments.
    • Funds to be used for capex, debt reduction, and corporate expansion.
  2. Increase in Authorized Capital & Borrowing Limits:
    • Enhancing capital structure to accommodate the fundraising initiative.
  3. Appointment of New Company Secretary:
    • Mr. R. Pramod Kumar was appointed as Company Secretary & Compliance Officer.

Management Commentary

Thirumalai Chemicals' Board of Directors stated:
"Despite challenging market conditions, our strategic fundraising will support long-term growth and operational efficiency. We remain focused on cost optimization and capacity expansion.".

Market Outlook & Investor Takeaways

  • Expansion plans are expected to drive future revenue growth and profitability.
  • Fundraising initiative to support debt reduction and new investments.
  • Continued focus on improving financial stability amid global demand fluctuations.
Thirumalai Chemicals' strategic initiatives and expansion efforts position it for long-term resilience.
 
Back
Top